Skip to content
Inciteful Med

Signs, Symptoms, and Look-Alikes: Identifying MCAS

Last updated:

Mast Cell Activation Syndrome (MCAS) causes episodic, severe allergy-like symptoms that affect at least two organ systems simultaneously. Unlike typical allergies, MCAS flares are triggered by non-specific factors and require careful medical testing to rule out similar conditions like POTS.

Key Takeaways

  • • To meet MCAS diagnostic criteria, symptoms must involve at least two organ systems during the same episode.
  • • MCAS is often triggered by non-specific factors like stress, heat, or physical vibration rather than specific allergens.
  • • Symptoms can include skin flushing, gastrointestinal distress, rapid heart rate, breathing difficulty, and sudden anxiety.
  • • Doctors must carefully rule out conditions with similar symptoms, such as POTS, HaT, and certain hormone-releasing tumors.
  • • While MCAS frequently occurs alongside POTS and hEDS, objective evidence like a tryptase rise is still required for an official diagnosis.

Because mast cells are located throughout the entire body—near blood vessels, nerves, and in the lining of your gut and airways—an MCAS “flare” can feel like an all-out assault on multiple systems at once [1][2]. Unlike a standard allergy to a bee sting or peanuts, which usually follows a predictable pattern, MCAS symptoms are often episodic, multisystemic, and triggered by non-specific factors like stress, heat, or even physical vibration [3][4].

The Multisystem Nature of MCAS

To meet the diagnostic criteria for MCAS, your symptoms must involve at least two of the following organ systems during the same episode [5][6]:

  • Skin (Dermatologic): This is the most common area affected. Symptoms include sudden flushing (redness), intense itching (pruritus), hives (urticaria), or swelling under the skin (angioedema) [1][7].
  • Gut (Gastrointestinal): You may experience severe abdominal cramping, nausea, vomiting, or sudden diarrhea. Some patients also deal with delayed gastric emptying, where food stays in the stomach too long [1][8].
  • Heart and Blood (Cardiovascular): A hallmark of a severe episode is a racing heart (tachycardia), a sudden drop in blood pressure (hypotension), or feeling like you are about to faint (syncope) [1][9].
  • Lungs and Airway (Respiratory): This can manifest as wheezing, shortness of breath (dyspnea), nasal congestion, or a frightening feeling of the throat swelling or closing [10][11].
  • Brain and Nerves (Neurologic): Many patients report “brain fog,” severe headaches, or sudden spikes in anxiety or panic during a flare [1][10]. It is important to know that “flare anxiety”—the sudden wave of panic during an episode—is often a direct chemical result of the inflammatory mediators your body is releasing, not just something “in your head” [1][12].

MCAS vs. “Normal” Allergies

It is easy to confuse MCAS with a typical IgE-mediated allergy. In a standard allergy, your immune system reacts to a specific protein (like pollen or shellfish). In MCAS, the mast cells are “twitchy” and can release their chemical cargo in response to almost anything, or even for no apparent reason at all [5][13].

While both can cause anaphylaxis—a life-threatening systemic reaction—MCAS episodes are often more frequent and can involve a wider range of symptoms, such as chronic GI distress or neurologic issues, that aren’t typically seen in a simple hay fever reaction [7][14].

Ruling Out the “Look-Alikes”

Because MCAS symptoms are so broad, doctors must carefully rule out other conditions that can mimic it. You can learn more about how they test for these in Pathology and Lab Reports.

Condition Why it looks like MCAS How it is different
POTS Causes racing heart, fainting, and lightheadedness [9]. POTS is a nervous system issue related to posture. While it can cause GI issues and flushing, it lacks the elevated mast-cell-specific biochemical markers (like a tryptase rise) seen in MCAS [15][9].
HaT Causes high baseline tryptase and multisystem symptoms [16]. This is a genetic trait (extra copies of a gene). It doesn’t require an acute “rise” in tryptase to explain the symptoms [17].
Carcinoid Syndrome Causes severe flushing and diarrhea [18]. This is caused by a slow-growing tumor that releases hormones. It is ruled out with specific urine and blood tests (like 5-HIAA) [19].
Pheochromocytoma Causes high blood pressure, racing heart, and sweating [18]. This is a rare tumor of the adrenal glands. It is ruled out by testing for “stress hormones” (metanephrines) in the blood or urine [20].

While there is a known “trifecta” where patients have MCAS, POTS, and hypermobile Ehlers-Danlos Syndrome (hEDS), doctors must still find objective evidence (like the tryptase rise) to confirm that mast cells are truly the cause of the symptoms, rather than the other conditions acting alone [21][2]. Return to the Home Page for the general diagnostic criteria.

Frequently Asked Questions

What are the common symptoms of an MCAS flare?
An MCAS flare typically involves at least two organ systems at the same time. Common symptoms include skin flushing, hives, severe abdominal cramping, a racing heart, sudden drops in blood pressure, and difficulty breathing.
How is MCAS different from a standard allergy?
A standard allergy is an immune reaction to a specific trigger, like pollen or a bee sting. In MCAS, mast cells are overly sensitive and can release inflammatory chemicals in response to almost anything, including stress, heat, or even for no apparent reason.
Why do I experience sudden anxiety or panic during an MCAS episode?
Sudden anxiety during an MCAS flare is often a direct chemical result of the inflammatory mediators your body releases. It is a physical symptom of the condition affecting your nervous system, rather than a purely psychological response.
Can POTS be mistaken for MCAS?
Yes, POTS can cause similar symptoms like a racing heart and lightheadedness. However, POTS is a nervous system issue related to posture and does not cause the elevated mast-cell-specific biochemical markers seen during an MCAS flare.
What triggers Mast Cell Activation Syndrome symptoms?
Unlike typical allergies, MCAS symptoms are often triggered by non-specific factors. Common triggers include emotional or physical stress, temperature changes like sudden heat, and physical vibration.

Questions for Your Doctor

  • • Do my symptoms involving my specific systems meet the threshold for 'multisystem involvement' required for MCAS?
  • • Could my symptoms be explained by POTS or hEDS alone, or is there objective evidence that mast cells are specifically responsible?
  • • How do we rule out 'look-alike' conditions like carcinoid syndrome or pheochromocytoma based on my specific lab results?
  • • Is it possible I have Hereditary Alpha-Tryptasemia (HaT) given my baseline tryptase levels?
  • • If my tryptase didn't rise during my last flare, are there other urinary mediators we should be testing?

Questions for You

  • • When I have a 'flare,' do the symptoms happen in at least two different parts of my body at the same time (e.g., skin flushing and stomach cramping)?
  • • Can I identify specific triggers like heat, stress, or vibration, or do my symptoms seem to happen randomly?
  • • How do my symptoms during a flare compare to a 'typical' allergy? Are they more widespread or accompanied by things like fainting or heart racing?
  • • Have I ever had a reaction so severe that I felt my throat closing or my blood pressure dropping significantly?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series.

    Weinstock LB, Nelson RM, Blitshteyn S

    Journal of personalized medicine 2023; (13(11)) doi:10.3390/jpm13111562.

    PMID: 38003876
  2. 2

    Diagnosis and Management of Patients With Mast Cell Activation Syndromes: Status 2026.

    Akin C, Gülen T, Castells MC, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(1)):19-28 doi:10.1016/j.jaip.2025.10.046.

    PMID: 41285202
  3. 3

    Beyond IgE-When Do IgE-Crosslinking and Effector Cell Activation Lead to Clinical Anaphylaxis?

    Poulsen LK, Jensen BM, Esteban V, Garvey LH

    Frontiers in immunology 2017; (8()):871 doi:10.3389/fimmu.2017.00871.

    PMID: 28848540
  4. 4

    Mast cell activation syndrome-anesthetic challenges in two different clinical scenarios.

    Lide B, Mcguire S, Liu H, Chandler C

    Journal of biomedical research 2022; (36(6)):435-439 doi:10.7555/JBR.36.20220071.

    PMID: 35660674
  5. 5

    Clinical Approach to Mast Cell Activation Syndrome: A Practical Overview.

    Matito A, Escribese MM, Longo N, et al.

    Journal of investigational allergology & clinical immunology 2021; (31(6)):461-470 doi:10.18176/jiaci.0675.

    PMID: 33541851
  6. 6

    How to diagnose mast cell activation syndrome: practical considerations.

    Romantowski J, Górska A, Lange M, et al.

    Polish archives of internal medicine 2020; (130(4)):317-323 doi:10.20452/pamw.15212.

    PMID: 32096778
  7. 7

    Recurrent Cyclic Vomiting and Gastroparesis-Like Symptoms in a Patient With Mast Cell Activation Syndrome (MCAS): A Case of Gastrointestinal-Predominant MCAS.

    Salib M, Music A, Salib J, et al.

    Cureus 2026; (18(2)):e103302 doi:10.7759/cureus.103302.

    PMID: 41835650
  8. 8

    A Review of the Dermatologic Symptoms of Idiopathic Mast Cell Activation Syndrome

    Qureshi AA, Friedman AJ

    Journal of drugs in dermatology : JDD 2019; (18(2)):162-168.

    PMID: 30794367
  9. 9

    Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy.

    Novak P, Giannetti MP, Weller E, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2022; (128(3)):299-306.e1 doi:10.1016/j.anai.2021.10.006.

    PMID: 34648976
  10. 10

    Patient characteristics of suspected mast-cell activation syndrome with sinonasal obstruction: a single institution experience.

    Kim JH, Xi S, Ference EH, et al.

    International forum of allergy & rhinology 2020; (10(8)):996-1000 doi:10.1002/alr.22558.

    PMID: 32407593
  11. 11

    Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.

    Brock I, Prendergast W, Maitland A

    American journal of medical genetics. Part C, Seminars in medical genetics 2021; (187(4)):473-481 doi:10.1002/ajmg.c.31940.

    PMID: 34747107
  12. 12

    COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?

    Theoharides TC, Conti P

    Journal of biological regulators and homeostatic agents 2020; (34(5)):1633-1636 doi:10.23812/20-EDIT3.

    PMID: 33023287
  13. 13

    Mast Cell Activation: When the Whole Is Greater than the Sum of Its Parts.

    Khokhar D, Akin C

    The Medical clinics of North America 2020; (104(1)):177-187 doi:10.1016/j.mcna.2019.09.002.

    PMID: 31757235
  14. 14

    Symptoms of mast cell activation syndrome in functional gastrointestinal disorders.

    Wilder-Smith CH, Drewes AM, Materna A, Olesen SS

    Scandinavian journal of gastroenterology 2019; (54(11)):1322-1325 doi:10.1080/00365521.2019.1686059.

    PMID: 31687861
  15. 15

    Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On.

    Schofield JR

    European journal of case reports in internal medicine 2021; (8(3)):002378 doi:10.12890/2021_002378.

    PMID: 33869099
  16. 16

    Mastocytosis and related entities: a practical roadmap.

    Beyens M, Elst J, van der Poorten ML, et al.

    Acta clinica Belgica 2023; (78(4)):325-335 doi:10.1080/17843286.2022.2137631.

    PMID: 36259506
  17. 17

    Case Report: Hereditary Alpha Tryptasemia in Children: A Pediatric Case Series and a Brief Overview of Literature.

    Zama D, Muratore E, Giannetti A, et al.

    Frontiers in pediatrics 2021; (9()):716786 doi:10.3389/fped.2021.716786.

    PMID: 34490168
  18. 18

    Mast Cell Activation Syndrome: Tools for Diagnosis and Differential Diagnosis.

    Weiler CR

    The journal of allergy and clinical immunology. In practice 2020; (8(2)):498-506 doi:10.1016/j.jaip.2019.08.022.

    PMID: 31470118
  19. 19

    [Tryptase: A practical guide for the physician].

    Lobbes H, Reynaud Q, Mainbourg S, et al.

    La Revue de medecine interne 2020; (41(11)):748-755 doi:10.1016/j.revmed.2020.06.006.

    PMID: 32712042
  20. 20

    Mast Cell Activation Syndrome and Gut Dysfunction: Diagnosis and Management.

    Hamilton MJ

    Current gastroenterology reports 2024; (26(4)):107-114 doi:10.1007/s11894-024-00924-w.

    PMID: 38353900
  21. 21

    Autonomic symptom burden, comorbidities and quality of life in women with Hypermobility Spectrum Disorders and hypermobile Ehlers-Danlos syndrome.

    Collins Hutchinson ML, Liang E, Fuster E, Blitshteyn S

    Autonomic neuroscience : basic & clinical 2025; (262()):103356 doi:10.1016/j.autneu.2025.103356.

    PMID: 41118678

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider for a proper evaluation of MCAS or its look-alike conditions.

Stay up to date

Get notified when new research about Mast Cell Activation Syndrome (MCAS) is published.

No spam. Unsubscribe anytime.